Green Resource Co

Core business of our Company is to produce/extract bio materials from animals organs, trading of textile waste and fish items. Our aim is to provide state of the art products/services to our valued customers at competitive cost and within time limits. Maintaining best quality of the products and honesty are core values of our company´s policy to keep our customer happy.

Graematter, Inc.

Graematter provides regulatory intelligence knowledge tools, research services, and expert consulting in the medical products industry. Supported by experienced professionals and a patented, proprietary knowledge management system, you can know what there is to know about medical products - the regulatory path, testing performed, adverse events, the sponsoring company, and the people who played a part in the process. Graematter's Regulatory Intelligence System A comprehensive, patented repository of regulatory information in the medical products industry. Soon to be accessible through subscription. Increase your efficiency and accuracy when developing true Regulatory Intelligence. Founder Graematter was founded by Melissa Walker, MS, RAC, FRAPS. An accomplished senior executive with over 25 years of experience, Melissa has proven expertise in business management, regulatory affairs, quality systems, healthcare compliance, and clinical research, Melissa founded Graematter to ease the burden of collecting and understanding regulatory intelligence.

GlyCardial Diagnostics

GlyCardial Diagnostics is a spin-off company of the Catalan Institute of Cardiovascular Sciences (ICCC) and the Spanish National Research Council (CSIC) focused on the development of a novel in vitro diagnostic device for myocardial ischemia. The technology is based on the detection of Apo J-Glyc in blood as a biomarker for the early diagnosis of cardiac ischemia and the prediction of patient's evolution after an ischemic event. GlyCardial Diagnostics was created by scientists Lina Badimon, Judit Cubedo, Teresa Padró and Gemma Vilahur. The company is located at the Hospital de la Santa Creu i Sant Pau Art Nouveau Site in Barcelona. In 2014, it was recognised as one of the most original, impactful technology projects in Spain in the MIT Technology Review awards for innovators under 35.

Efferent Labs, Inc.

About Efferent Labs Efferent Labs Inc. is a pre-clinical stage company focused on biosensor systems for life sciences. Our proprietary technology is showcased in our Living Biosensor System, an in-vivo, real time monitoring system for biological signaling and cellular responses. Our Biosensor System is unique as it employs living cell lines, a powerful tool to assess cellular function in-vivo. The system transmits live data through the cloud to our data acquisition and analysis software. Using our system, real time results are available to researchers at their desk or in remote locations. For more information about our technology, see the Products & Technology section of this website. www.efferentlabs.com

allahdin group of companies